ACWA, ECOHZ partner to empower local communities

The project in Morocco aims to increase the income and employability of communities. (Photo by WOCAN)
Updated 23 December 2018

ACWA, ECOHZ partner to empower local communities

ACWA Power, a water desalination and power generation firm, recently collaborated with a key player in energy sector, ECOHZ, which offers global renewable energy solutions to businesses, organizations and electricity providers, to empower local women and support communities in Morocco. 

“Stemming from its commitment to communities it operates in, and following its development of the world’s largest concentrated solar power plan project, Noor Power Plant in Morocco, ACWA Power concludes the year by empowering women around the planet through increasing income and employability and improving education,” a press release said. 

ACWA Power works closely with WOCAN, the international membership network working toward gender equality, and creator of W+ Standard (W+), which measures the impact of projects on women’s empowerment and increases their access to resources and capital, scaling up solutions to climate change, food security and poverty. 

The CSR project increases income and improves livelihoods of the local female population. It recognizes the social capital created by women, rewards women’s contributions to sustainable environment communities, provides access to women in local communities to basic needs including education and health care, and increases the income and employability of women to help ensure gender equality. 

Paddy Padmanathan, president and CEO of ACWA Power, said: “We are passionate about our model of developing plants in remote areas and actively collaborating with the local communities. This results in empowerment of local communities, creation of employment opportunities, and generation of economic activity — which we consider our long-term commitment.”

We are proud to be working with W+ to contribute toward increasing income and employability.” 

Tom Lindberg, managing director at ECOHZ, added: “We work to change corporations’ energy behavior and are enthusiastic to be able to empower women at the same time — contribute to both SDG 7 (clean energy) and SDG 5 (gender equality).”

In coordination with WOCAN’s pursuit of sustainable development, it has been reported that W+ is the first instrument that offers the possibility to measure, verify, and report the fifth and seventh critical sustainable development goals (SDGs), which are part of the larger 17 SDGs set by the United Nations General Assembly in 2015. 

The collaboration between ACWA Power, ECOHZ and WOCAN has been able to heavily contribute to these SDG’s and consequently amplify the welfare of women in Morocco.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.